Aveza Pharmaceuticals Private Limited
About Aveza Pharmaceuticals Private Limited
Data last updated:
Aveza Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 January 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2011PTC033852. Its GSTIN is 08AAJCA3310P1ZJ (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anita Sharma and Mahendra Prasad Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C 194 Jda Colony Malviya Nagar, Jaipur, Rajasthan, India – 302017.
As per the financials filed for FY 2025, the company reported a revenue of ₹57.37 Lakh, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹30,227 (net margin 0.5%) and EBITDA of ₹90,022 (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 17% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC 194 Jda Colony Malviya Nagar, Jaipur, Rajasthan, India – 302017
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aveza Pharmaceuticals Private Limited
The main business activity of Aveza Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aveza Pharmaceuticals Private Limited FY 2025 filings available
Aveza Pharmaceuticals Private Limited reported revenue of ₹57.37 Lakh (up 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aveza Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 34% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aveza Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹90,022 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹30,227 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aveza Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aveza Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Aveza Pharmaceuticals Private Limited
Aveza Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| S Square Pharmaceuticals Private Limited | ₹57.5 Lakh (FY 2024) | •••• | •••• | 14.0% | •••• | Patna, Bihar, India |
| Pearl Medilife Private Limited | ₹57.5 Lakh (FY 2024) | •••• | •••• | 7.0% | •••• | Ahmedabad, Gujarat, India |
| Medwaala Pharmaceuticals Private Limited | ₹57.45 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Delhi, India |
| Borra Health Care Private Limited | ₹57.39 Lakh (FY 2023) | •••• | •••• | 5.0% | •••• | Hyderabad, Telangana, India |
| Neumorgen Pharmaceuticals Private Limited | ₹57.37 Lakh (FY 2025) | •••• | •••• | 48.0% | •••• | Sahibabad, Uttar Pradesh, India |
| Aveza Pharmaceuticals Private Limited this company | ₹57.37 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Jaipur, Rajasthan, India |
| Egzeon Pharmaceuticals Private Limited | ₹57.23 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Ambala Cantt, Haryana, India |
| Novostar Pharmaceuticals Private Limited | ₹57.22 Lakh (FY 2025) | •••• | •••• | 119.0% | •••• | Ambala, Haryana, India |
| Capricon Pharmaceuticals Private Limited | ₹57.19 Lakh (FY 2018) | •••• | •••• | -59.0% | •••• | New Delhi, Delhi, India |
| Ms Bio Pharmaceuticals Private Limited | ₹57.16 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Arvoni Lifesciences Private Limited | ₹57.03 Lakh (FY 2025) | •••• | •••• | -58.0% | •••• | Zirakpur, Punjab, India |
Peers are the five companies nearest above and the five nearest below Aveza Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Aveza Pharmaceuticals Private Limited
Aveza Pharmaceuticals Private Limited is audited by SHAILENDRA B AGARWAL & CO for the financial year 2016.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHAILENDRA B AGARWAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aveza Pharmaceuticals Private Limited
Aveza Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anita Sharma | Director | 15 Feb 2017 | 9 Years 7 Months | Current |
| Mahendra Prasad Sharma | Director | 15 Feb 2017 | 9 Years 7 Months | Current |
Ownership and Shareholding of Aveza Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aveza Pharmaceuticals Private Limited
Aveza Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aveza Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Aveza Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aveza Pharmaceuticals Private Limited
Aveza Pharmaceuticals Private Limited has 6 board changes on record since 2011: 2 appointments and 4 cessations. The latest: Ajay Teng ceased to be Director on 28 Feb 2017.
Credit Ratings, Litigation & Regulatory Alerts for Aveza Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aveza Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aveza Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aveza Pharmaceuticals Private Limited
Aveza Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAJCA3310P1ZJ | Rajasthan | Active | 22 May 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aveza Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aveza Pharmaceuticals Private Limited
Aveza Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 January 2011 (15+ years old) and is registered under CIN U24232RJ2011PTC033852.
Aveza Pharmaceuticals reported revenue of ₹57.37 Lakh for FY 2025 (up 34% YoY).
Aveza Pharmaceuticals has 2 current directors:
- Anita Sharma - Director
- Mahendra Prasad Sharma - Director
Aveza Pharmaceuticals reported a net profit of ₹30,227 (net margin 0.5%) and EBITDA of ₹90,022 (EBITDA margin 1.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aveza Pharmaceuticals is 27% over three years and 17% over five years. In the latest year (FY 2025) revenue rose 34%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aveza Pharmaceuticals is 08AAJCA3310P1ZJ, registered in Rajasthan.
The CIN (Corporate Identification Number) of Aveza Pharmaceuticals is U24232RJ2011PTC033852. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aveza Pharmaceuticals was incorporated on 13 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Aveza Pharmaceuticals by revenue are S Square Pharmaceuticals Private Limited, Pearl Medilife Private Limited, Medwaala Pharmaceuticals Private Limited, Borra Health Care Private Limited, Neumorgen Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Ajay Teng ceased to be Director on 28 Feb 2017. Ruchi Teng ceased to be Director on 28 Feb 2017. Anita Sharma was appointed as Director on 15 Feb 2017. Aveza Pharmaceuticals has 6 board changes on record in total.
The registered office of Aveza Pharmaceuticals is at C 194 Jda Colony Malviya Nagar, Jaipur, Rajasthan, India – 302017.